A carregar...
Molecular monitoring of chronic myeloid leukemia: present and future
INTRODUCTION: Fusion of BCR-ABL1 genes causes chronic myeloid leukemia (CML). As a reliable marker of disease burden, it also serves as the target of tyrosine kinase inhibitors (TKIs). New more sensitive molecular diagnostic tools for BCR-ABL1 can contribute to therapeutic decision-making, especiall...
Na minha lista:
| Publicado no: | Expert Rev Mol Diagn |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161535/ https://ncbi.nlm.nih.gov/pubmed/27552202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737159.2016.1227243 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|